Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies

INTRODUCTION: “Re-infection” with COVID-19 is a growing concern; re-infection cases have reported worldwide. However, the clinical characteristics of SARS-CoV-2 re-infection, including the levels and role of anti-SARS-CoV-2 Spike protein IgG antibodies and the half-maximal concentration (IC(50)) of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Chemother
Autors principals: Inada, Makoto, Ishikane, Masahiro, Terada, Mari, Matsunaga, Akihiro, Maeda, Kenji, Tsuchiya, Kiyoto, Miura, Kenji, Sairenji, Yu, Kinoshita, Noriko, Ujiie, Mugen, Kutsuna, Satoshi, Ishizaka, Yukihito, Mitsuya, Hiroaki, Ohmagari, Norio
Format: Artigo
Idioma:Inglês
Publicat: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064832/
https://ncbi.nlm.nih.gov/pubmed/33962861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2021.04.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars